ms masterclass 6 2 17 may 2019
play

MS Masterclass 6.2 17 May 2019 Case Presentations Dr John Thorpe - PowerPoint PPT Presentation

MS Masterclass 6.2 17 May 2019 Case Presentations Dr John Thorpe Case 1 History 37 year old agricultural machine worker First seen April 2016 Diplopia (with INO to left) Dysarthria Dysphagia Left sided weakness and


  1. Examination • ?slightly dysarthric • Acuity reduced in (amblyopic) L eye • Normal colour vision and fundi • Mild difficulty tandem walking and hopping • Mild weakness of right hip flexion and ankle dorsiflexion • Moderately brisk reflexes • Equivocal plantars • Reduced pinprick sensation in right foot and ulnar three fingers of right hand

  2. Summary • 52 year old woman • Recurrent (abrupt) neurological episodes since 20s • Corneal dystrophy, cataracts, bowel perforation, +/- deafness • Possible FH of renal disease • Relatively minor signs on examination • Should she have Lemtrada?

  3. Investigations – Routine haematology and biochem normal – MRI – CSF • Normal. Negative OCBs

  4. MRI

  5. MRI

  6. What Now? – Slightly indignant email • Already seen several neurologists • Wants Alemtuzumab ++

  7. Does she have MS? – Susac’s • Normal angio • ?Relevance of corneal dystrophy – ?Vascular • Fabry’s

  8. Investigations – Repeat MRI • unchanged – Repeat CSF • Normal again. Negative OCBs

  9. Investigations – ESR normal – Thrombophilia screen normal – Complement N – ACE N – White cell enzymes normal – ANA/ANCA Neg – Alpha-galactosidase normal

  10. Investigations – GEMINI panel – Heterozygous likely pathological variant in COL3A1 • Procollagen III • Type III collagen – Vascular Ehlers-Danlos syndrome (IV)

  11. Vascular Ehlers-Danlos Syndrome – Variable hypermobility, skin fragility – Predominantly large vessel disease • Vascular rupture/dissection • Also intestinal rupture • Uterine rupture – Valvular prolapse – Spontaneous pneumothorax – No definite association with MS – ?Corneal dystrophy

  12. Small fibre neuropathy

  13. Cazzato et al

  14. Progress • Still being managed as OCB neg MS • Started on Tecfidera but did not tolerate – (worsening abdominal pain and diarrhoea) • Reviewed – No problems with wound healing or dislocations – Renal history in daughter still not clear – No other FH

  15. Progress • No hypermobility • Easily palpable aorta – (CTA normal) • Various scars • Referred to genetics

  16. Genetic Review • Mutation highly likely to be pathogenic – Null mutation in COL3A1 – History of dislocated shoulder, easy bruising, varicose veins from teens and joint pains

  17. Genetic Review – O/E • “Facial Gestalt of EDS IV” • Acrogeria • Translucent skin on chest and arms • Smooth skin with striae • Varicose veins • No hypermobility

  18. Progress • Awaiting cardiology review • Also undergoing further GI investigations • Not currently on DMT

  19. Case 3 • 42 year old M • Previously fit and active – Boxed aged 8 to 18 – Almost made it to Olympic team

  20. History • 42 year old M • Previously fit and active – Boxed aged 8 to 18 – Almost made it to Olympic team – Longstanding mental health problems • Anxiety • Depression • Agoraphobia : housebound for years

  21. History • Moved house in August 2017 – Partner’s children going to school locally • “Acute stress reaction” – Appeared to be in a trance – Disorientated – Unable to follow instructions – Confused with poor memory

  22. History • Ongoing problems – Just sitting in front of TV – Staring into the distance – Unable to follow simple commands – Needing prompting to eat and drink – Sending odd texts to his parents “just random letters” – Poor spatial awareness • Walking into door frames – CT …

  23. CT

  24. History • October 2017 – Possibly some improvement in cognition – Abrupt onset of walking mobility – Shaking of right arm and leg – Unsteady – Had to start sleeping downstairs • December 2017 – Wheelchair bound – Only able to take a couple of steps – Incontinent

  25. History • PMH – Longstanding psychiatric problems • 1991 “Phobic anxiety disorder” – No previous neurological symptoms • Meds – Citalopram 40mg, Diazepam 2mg tds, Propranolol 40mg prn,Omeprazole 20mg od • Smokes. No EtOH (previously heavy) – Previous illicit drugs esp cocaine • No FH

  26. Examination • Broken pursuit • Discs normal • ?Tic • Increased jaw jerk • Increased tone in all four limbs • Brisk reflexes, clonus, ext plantars

  27. History/Examination cont • December 2017 – Further deterioration – Unable to stand • Examination – Very anxious and agitated – Wearing dark glasses – Not orientated in time or place – Mild incoordination – Moderate pyramidal weakness of legs

  28. Summary • 42 year old man • Former boxer • Long psychiatric history • 5 month history of cognitive symptoms • 3 month history of mobility problems and incontinence • Abnormal CT scan

  29. Investigations • CT diffuse white matter low attenuation • FBC, Biochem, ESR Normal (low phosphate), normal electrophoresis • Complement normal • Lactate normal • ANA, ANCA, Anticardiolipin Neg • HIV neg

  30. Investigations • MRI • CSF – WCC 42 (90%) lymphs – Protein 0.95 g/L – Glucose 3.2/5.0 – Locally synthesised OCBs

  31. Balo Concentric Sclerosis • Balo J. Leucoencephalitis periaxialis concentrica. Magy Orvosi Arch 1927;28:108-24 • (Marburg 1906) • Acute CNS disorder with concentric rings of demyelination alternating with relatively myelinated tissues • Initially pathological (PM) diagnosis • Similar appearances on MRI • ?Just severe acute MS – ~half of cases in literature in context of MS – Not all develop MS – OCBs often absent

  32. Balo concentric sclerosis

  33. Balo Concentric Sclerosis • F 55% • Mean age of onset 34 • Presentation – Progressive encephalopathy – Fever – Behavioral changes – Cognitive deficits – Headache, seizures – Increased intracranial pressure – Focal neurologic deficits – Stroke like presentation described – Rare asymptomatic MRI changes

  34. Balo Concentric Sclerosis • Course – Subacute, progressive, fatal – Prognosis often <1 year – Monophasic, relapsing, progressive • Treatment ?? – Acute • Steroids • Immunosuppressants • Plasmaphoresis • IVIG

  35. Balo Concentric Sclerosis • Treatment ?? – Chronic • MS DMTs • Azathioprine • Mitoxantrone • Cyclophosphamide • ?Natalizumab • Alemtuzumab ineffective (n=1) – Brown, Coles, Jones Mult Scler 2013 • Prognosis – Initially PM diagnosis… • 14% dead or severely disabled in a year • 3% ?Devic • 19% MS like course • 26% stable >2 years • 38% stable FU < 2 years

  36. Balo Concentric Sclerosis • Mechanism – ?NO and oxygen free radicals inhibiting COX-1 – Induced protective HIF-1 alpha and HSP-70 in adjacent oligodendrocytes – Other clever mathematical models based in non-linear chemotaxis…

  37. Progress • IVMP 1g x 3 days • Commenced on Pred 60mg • Temporary improvement for a few days • Unable to walk again • Doubly incontinent • Plan for PLEx • IVIG – No improvement

  38. Progress • IVMP 1g x 3 days • Commenced on Pred 60mg • Temporary improvement for a few days • Unable to walk again • Doubly incontinent • Plan for PLEx • IVIG – No initial improvement

  39. Progress • Oct 2018 • Gradual improvement over months • Mostly continent • Transferring from bed to commode/wheelchair • Cognitive issues ?functional component – Had further psychiatric review

  40. Examination • Not orientated in place or time • Tone increased in legs with extensor spasms • Normal power • DNAd repeat MRI

  41. Case 4

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend